Methanesulfonyl chloride → (3-{[3-(2-Chloro-pyrimidin-4-yl)-benzyl]-methanesulfonyl-amino}-propyl)-carbamic acid tert-butyl ester
반응식
[C:1]([O:5][C:6](=[O:26])[NH:7][CH2:8][CH2:9][CH2:10][NH:11][CH2:12][C:13]1[CH:18]=[CH:17][CH:16]=[C:15]([C:19]2[CH:24]=[CH:23][N:22]=[C:21]([Cl:25])[N:20]=2)[CH:14]=1)([CH3:4])([CH3:3])[CH3:2].[CH3:27][S:28](Cl)(=[O:30])=[O:29]>>[C:1]([O:5][C:6](=[O:26])[NH:7][CH2:8][CH2:9][CH2:10][N:11]([CH2:12][C:13]1[CH:18]=[CH:17][CH:16]=[C:15]([C:19]2[CH:24]=[CH:23][N:22]=[C:21]([Cl:25])[N:20]=2)[CH:14]=1)[S:28]([CH3:27])(=[O:30])=[O:29])([CH3:4])([CH3:2])[CH3:3]참가 물질
3
실험 절차
Intermediate 2 from above was treated with methanesulfonyl chloride following procedure D. LC-MS showed the product had the expected M+H+ of 456.
출처 및 근거
- ORD 기록
- ord-e82a31e58c8440abbe1f0de6fc321f26
- 출처 데이터셋
- uspto-grants-2012_09
- 특허 번호
- US08268822B2
반응 노트
불러오는 중…